TELA Bio Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 04:30PM GMT
Mike Sarcone - Jefferies - Analyst

All right. I think we can kick this off. Good afternoon, and welcome everybody to the Jefferies 2023 Healthcare Conference. My name is Mike Sarcone. I'm an analyst on the medical supplies and devices team. And for this session, we're happy to have with us TELA Bio. And TELA Bio is an innovator in soft tissue repair, particularly in the areas of hernia and abdominal wall reconstruction and plastic and reconstructive surgery.

And with us from the company today, we've got Tony Koblish, CEO; and Roberto Cuca, CFO and COO. So gentlemen, thank you for joining us.

And maybe just to start off for those who are listening that may not be familiar with the TELA Bio story. Tony, can you kick us off and just give us a high-level overview of what TELA does and the value prop and how you guys are innovating?

Tony Koblish - TELA Bio, Inc. - Co-Founder, President & CEO

Absolutely. Thank you, Michael, and thank you to Jefferies for the invitation to the conference. TELA Bio is a commercial-stage company, small-cap medtech

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot